FLT3 and acute myeloid leukemia: Beyond conventional catabolic dependencies, FLT3-ITD-mutated AML demonstrates extensive metabolic reprogramming that encompasses amino acid utilization, one-carbon unit transfer reactions, and anabolic flux through the pentose phosphate pathway (PPP)—encompassing cellular processes fundamental to nucleotide biosynthesis, maintenance of redox homeostasis, and membrane component generation.